ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Romark Initiates Phase 3 Clinical Trials Of NT-300 for COVID-19 americanpharmaceuticalreview
April 30, 2020Romark will initiate two clinical trials of its investigational new drug candidate NT-300 (nitazoxanide extended-release tablets) for prevention of COVID-19 and other viral respiratory illnesses in high-risk populations.
Pharma Sources Insight January 2025
